early gastric cancer
Conditions
Interventions
Administration of famotidine 40mg P.O./day for 8weeks
Administration of famotidine 40mg P.O./day for 1day and omeprazole 40mg I.V./day for 3days after ESD and omeprazole 20mg P.O./day for 7weeks and 4
Sponsors
Hyogo College of Medicine Upper gastroenterology Department of internal medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. early gastric cancer patients who undergo ESD 2. patients who are older than 20 years at entry. 3. patients who understand the study contents and give informed consents by themselves
Exclusion criteria
Exclusion criteria: 1. patients with severe liver, renal and cardiopulumonary diseases. 2. patients who took medicines described below within one week before the first day of the study; H2RA, PPI 3. patients who had underwent eradication therapy for H.pylori within 6 months before the first day of the study 4. patients who are pregnancy, in breast-feeding or who wish pregnancy during the study period. 5. patients who are regarded in-eligible by the doctor who participates in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Retio of delayed bleeding(hematemesis or melena required endoscopic hemostasis, decreased the hemoglobin count by more than 2g/dl) | — |
Secondary
| Measure | Time frame |
|---|---|
| The curative rate for ulcer after ESD at 6 weeks later | — |
Countries
Japan
Contacts
Public ContactYongmin Kim
Hyogo College of Medicine Upper gastroenterology Department of internal medicine
Outcome results
None listed